SAKAR HEALTHCARE
Back to Balance Sheet
|
SAKAR HEALTHCARE Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹2.66 Cr | ₹2.29 Cr | ₹1.70 Cr | ₹1.44 Cr | ₹0.79 Cr |
What is the latest Long Term Provisions ratio of SAKAR HEALTHCARE ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹2.66 Cr |
| Mar2024 | ₹2.29 Cr |
| Mar2023 | ₹1.70 Cr |
| Mar2022 | ₹1.44 Cr |
| Mar2021 | ₹0.79 Cr |
How is Long Term Provisions of SAKAR HEALTHCARE Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹2.66 Cr | 16.26 | |
| Mar2024 | ₹2.29 Cr | 34.75 | |
| Mar2023 | ₹1.70 Cr | 18.08 | |
| Mar2022 | ₹1.44 Cr | 81.34 | |
| Mar2021 | ₹0.79 Cr | - | |
Compare Long Term Provisions of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹947.3 Cr | 2.9% | 15% | 40.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹416,884.0 Cr | -0.5% | -1.9% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,442.0 Cr | 1.8% | 1.3% | 10.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,770.0 Cr | 2% | 2.4% | 11.2% | Stock Analytics | |
| CIPLA | ₹120,871.0 Cr | -0.2% | -0.7% | 1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,693.0 Cr | -1% | 2.5% | -4.4% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | 2.9% |
15% |
40.6% |
| SENSEX | 1% |
0.6% |
7.8% |
You may also like the below Video Courses